Global and regional cancer burden attributable to modifiable risk factors in 2022: Evidence to guide cancer prevention
Hanna Fink(Centre international de recherche sur le cancer), Isabelle Soerjomatarm(Centre international de recherche sur le cancer), Lucero Lopez-Perez(World Health Organization - Pakistan), Marilina Santero(Universitat Autònoma de Barcelona), Jérôme Vignat(Centre International de Recherche sur le Cancer), Harriet Rumgay(Centre international de recherche sur le cancer), Kevin D. Shield(Western University), Ricardo X Martinez(World Health Organization), Manami Inoue(Fukuoka University), André Ilbawi(World Health Organization), Oliver Langselius(Centre international de recherche sur le cancer), Jürgen Rehm(Centre for Addiction and Mental Health), Hongmei Zeng(Chinese Academy of Medical Sciences & Peking Union Medical College), Eileen Morgan(Centre international de recherche sur le cancer)
Cited by 1
Related Papers
Current and future burden of breast cancer: Global statistics for 2020 and 2040
|The Breast|2022|3.3k
The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
|PLoS Medicine|2009|2.9k
Global burden of primary liver cancer in 2020 and predictions to 2040
|Journal of Hepatology|2022|2.1k
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
|JAMA Dermatology|2022|1.4k